| 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus H Masur, JE Kaplan, KK Holmes, BL Alston, N Ampel, JR Anderson, ... Clinical Infectious Diseases 30, S29-S65, 2000 | 908* | 2000 |
| The survival benefits of AIDS treatment in the United States RP Walensky, AD Paltiel, E Losina, LM Mercincavage, BR Schackman, ... The Journal of infectious diseases 194 (1), 11-19, 2006 | 742 | 2006 |
| Diagnostic point-of-care tests in resource-limited settings PK Drain, EP Hyle, F Noubary, KA Freedberg, D Wilson, WR Bishai, ... The Lancet infectious diseases 14 (3), 239-249, 2014 | 704 | 2014 |
| Expanded screening for HIV in the United States—an analysis of cost-effectiveness AD Paltiel, MC Weinstein, AD Kimmel, GR Seage III, E Losina, H Zhang, ... New England Journal of Medicine 352 (6), 586-595, 2005 | 696 | 2005 |
| The cost effectiveness of combination antiretroviral therapy for HIV disease KA Freedberg, E Losina, MC Weinstein, AD Paltiel, CJ Cohen, GR Seage, ... New England Journal of Medicine 344 (11), 824-831, 2001 | 641 | 2001 |
| The lifetime cost of current human immunodeficiency virus care in the United States BR Schackman, KA Gebo, RP Walensky, E Losina, T Muccio, PE Sax, ... Medical care 44 (11), 990-997, 2006 | 600 | 2006 |
| The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men SJ Goldie, KM Kuntz, MC Weinstein, KA Freedberg, ML Welton, ... Jama 281 (19), 1822-1829, 1999 | 518 | 1999 |
| Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa CB Holmes, E Losina, RP Walensky, Y Yazdanpanah, KA Freedberg Clinical infectious diseases 36 (5), 652-662, 2003 | 407 | 2003 |
| HIV/AIDS, undernutrition, and food insecurity LC Ivers, KA Cullen, KA Freedberg, S Block, J Coates, P Webb, KH Mayer Clinical Infectious Diseases 49 (7), 1096-1102, 2009 | 353 | 2009 |
| Cost-effectiveness of HIV treatment in resource-poor settings—the case of Côte d'Ivoire SJ Goldie, Y Yazdanpanah, E Losina, MC Weinstein, X Anglaret, ... New England Journal of Medicine 355 (11), 1141-1153, 2006 | 334 | 2006 |
| Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection TM Allen, M Altfeld, XG Yu, KM O'Sullivan, M Lichterfeld, S Le Gall, ... Journal of virology 78 (13), 7069-7078, 2004 | 324 | 2004 |
| HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness AD Paltiel, KA Freedberg, CA Scott, BR Schackman, E Losina, B Wang, ... Clinical Infectious Diseases 48 (6), 806-815, 2009 | 313 | 2009 |
| Alcohol consumption and antiretroviral adherence among HIV‐infected persons with alcohol problems JH Samet, NJ Horton, S Meli, KA Freedberg, A Palepu Alcoholism: Clinical and Experimental Research 28 (4), 572-577, 2004 | 308 | 2004 |
| Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness MC Weinstein, SJ Goldie, E Losina, CJ Cohen, JD Baxter, H Zhang, ... Annals of internal medicine 134 (6), 440-450, 2001 | 308 | 2001 |
| Prevention of prescription opioid misuse and projected overdose deaths in the United States Q Chen, MR Larochelle, DT Weaver, AP Lietz, PP Mueller, S Mercaldo, ... JAMA network open 2 (2), e187621-e187621, 2019 | 296 | 2019 |
| Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs AD Paltiel, RP Walensky, BR Schackman, GR Seage III, ... Annals of internal medicine 145 (11), 797-806, 2006 | 269 | 2006 |
| Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis PE Sax, R Islam, RP Walensky, E Losina, MC Weinstein, SJ Goldie, ... Clinical infectious diseases 41 (9), 1316-1323, 2005 | 263 | 2005 |
| The cost-effectiveness of preventing AIDS-related opportunistic infections KA Freedberg, JA Scharfstein, GR Seage III, E Losina, MC Weinstein, ... Jama 279 (2), 130-136, 1998 | 263 | 1998 |
| CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment CB Holmes, R Wood, M Badri, S Zilber, B Wang, G Maartens, H Zheng, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (4), 464-469, 2006 | 255 | 2006 |
| Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late initiation, and early discontinuation of … E Losina, BR Schackman, SN Sadownik, KA Gebo, RP Walensky, ... Clinical Infectious Diseases 49 (10), 1570-1578, 2009 | 252 | 2009 |
